Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Fukuda

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Biochemical and Biophysical Research Communications|November 5, 2002
Identification of the novel splicing variants for the hPXR in human liversShuichi Fukuen, Tsuyoshi Fukuda, Hideyasu Matsuda, et al.
Pharmacogenetics|June 4, 2002
Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese populationShuichi Fukuen, Tsuyoshi Fukuda, Hiromi Maune, et al.
Drug Metabolism and Pharmacokinetics|April 28, 2005
The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitutionYuka Ikenaga, Tsuyoshi Fukuda, Kazuhiro Fukuda, et al.
British Journal of Clinical Pharmacology|December 22, 2016
Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours: a report from the Children's Oncology GroupTomoyuki Mizuno, Tsuyoshi Fukuda, Uwe Christians, et al.
European Journal of Clinical Pharmacology|August 26, 2003
Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteersMasahiro Otani, Tsuyoshi Fukuda, Masakazu Naohara, et al.
Neuropsychobiology|March 12, 2008
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depressionMasaki Kato, Masataka Wakeno, Gaku Okugawa, et al.
Clinical Pharmacokinetics|December 15, 2010
The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune diseaseCatherine M T Sherwin, Tsuyoshi Fukuda, Hermine I Brunner, et al.
Journal of Clinical Pharmacology|December 31, 2020
Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future ApproachesBrooks T McPhail, Chie Emoto, Dawn Butler, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 2, 2004
Spontaneous closure of ventricular septal defects followed up from <3 months of ageToshiharu Miyake, Tohru Shinohara, Yoshihide Nakamura, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2005
Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disordersTsuyoshi Fukuda, Kazuhiro Takahashi, Takashi Suzuki, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|November 5, 2002
Identification of the novel splicing variants for the hPXR in human liversShuichi Fukuen, Tsuyoshi Fukuda, Hideyasu Matsuda, et al.
Pharmacogenetics|June 4, 2002
Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese populationShuichi Fukuen, Tsuyoshi Fukuda, Hiromi Maune, et al.
Drug Metabolism and Pharmacokinetics|April 28, 2005
The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitutionYuka Ikenaga, Tsuyoshi Fukuda, Kazuhiro Fukuda, et al.
British Journal of Clinical Pharmacology|December 22, 2016
Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours: a report from the Children's Oncology GroupTomoyuki Mizuno, Tsuyoshi Fukuda, Uwe Christians, et al.
European Journal of Clinical Pharmacology|August 26, 2003
Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteersMasahiro Otani, Tsuyoshi Fukuda, Masakazu Naohara, et al.
Neuropsychobiology|March 12, 2008
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depressionMasaki Kato, Masataka Wakeno, Gaku Okugawa, et al.
Clinical Pharmacokinetics|December 15, 2010
The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune diseaseCatherine M T Sherwin, Tsuyoshi Fukuda, Hermine I Brunner, et al.
Journal of Clinical Pharmacology|December 31, 2020
Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future ApproachesBrooks T McPhail, Chie Emoto, Dawn Butler, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|April 2, 2004
Spontaneous closure of ventricular septal defects followed up from <3 months of ageToshiharu Miyake, Tohru Shinohara, Yoshihide Nakamura, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2005
Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disordersTsuyoshi Fukuda, Kazuhiro Takahashi, Takashi Suzuki, et al.
Pageof 12